Profilo
Jenna Daly is currently Vice President-Clinical Operations at Janux Therapeutics, Inc. Formerly, Ms. Daly was Senior Director-Project Management at SynteractHCR Corp.
from 2020 to 2021 and Manager-Clinical Operations at CancerVax Corp.
from 2004 to 2006.
Education includes an undergraduate degree from the University of California, Los Angeles and an MBA from San Diego State University.
Posizioni attive di Jenna Daly
| Società | Posizione | Inizio |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Jenna Daly
| Società | Posizione | Fine |
|---|---|---|
SynteractHCR Corp.
SynteractHCR Corp. Pharmaceuticals: MajorHealth Technology Engaged in outsourced pharmaceutical services | Corporate Officer/Principal | 01/05/2021 |
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Direttore Tecnico/Scientifico/R&S | 01/02/2006 |
Formazione di Jenna Daly
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
CancerVax Corp.
CancerVax Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops products for the prevention, treatment, and control of cancer | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SynteractHCR Corp.
SynteractHCR Corp. Pharmaceuticals: MajorHealth Technology Engaged in outsourced pharmaceutical services | Health Technology |
Janux Therapeutics, Inc.
Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
















